STOK Deferred Revenue
Stoke Therapeutics Inc · Deferred Revenue
STOK Deferred Revenue
Latest reported$8.52Mperiod ending
STOK Quarterly Deferred Revenue ($0.00 → $8.52M)
Quarterly deferred revenue
High-resolution chart · PNG
STOK deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 8,523,000 | |
| 10,066,000 | |
| 11,901,000 | |
| 5,763,000 | |
| 8,749,000 | |
| 18,164,000 | |
| 18,991,000 | |
| 31,612,000 | |
| 26,051,000 | |
| 20,918,000 | |
| 15,309,000 | |
| 8,735,000 | |
| 8,059,000 | |
| 13,451,000 | |
| 14,880,000 | |
| 12,838,000 | |
| 10,634,000 | |
| 8,469,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |